mRNA Vaccine 3

Domestic supply of Moderna consignment production to Samsung Bio ‘misfire’

The lack of a vaccine hub strategy was revealed as the government and Samsung Biologics demanded that Moderna's domestic supply of contract vaccines failed. Kang Do-tae, 1st General Coordinator (Second Vice Minister of Welfare) of the Ministry of Health and Welfare, said as a result of a request for domestic supply of finished products in September for Samsung Bio consignment production during a..

카테고리 없음 2021.08.17

2.2 trillion won national strategy input to the level of K vaccine ‘candidate material laboratory’

As the ribonucleic acid (mRNA) candidate for the K-vaccine injection strategy of 2.2 trillion won is still being tested for immunogenicity in the laboratory, distrust is raised about the “application for emergency use approval in the first half of next year” that was announced in April. done. President Moon Jae-in announced to the Global Vaccine Hub Promotion Committee that was launched on the 5..

카테고리 없음 2021.08.05

Pfizer vaccine successfully manufactured in China, bureaucrats'mistake' for failure in Korea

It seems that the Blue House officials took the lead in attracting Pfizer vaccine consignment production and failed because they were pushed by China. Fuxing Pharmaceuticals, a subsidiary of China's Fuxing Pharmaceutical Group, announced on the 9th that it was a joint venture (joint venture) between Bioentech in Germany, but Samsung Biologics announced on the 12th that it was not true of the Kor..

카테고리 없음 2021.05.13